首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
The FDA revises requirements for levothyroxine products
被引:10
|
作者
:
Burman, Kenneth
论文数:
0
引用数:
0
h-index:
0
机构:
Georgetown Univ, Washington, DC 20057 USA
Univ Hlth Sci, Bethesda, MD USA
Georgetown Univ, Washington, DC 20057 USA
Burman, Kenneth
[
1
,
2
]
Hennessey, James
论文数:
0
引用数:
0
h-index:
0
机构:
Harvard Univ, Sch Med, Boston, MA USA
Georgetown Univ, Washington, DC 20057 USA
Hennessey, James
[
3
]
McDermott, Michael
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Colorado, Denver, CO 80202 USA
Georgetown Univ, Washington, DC 20057 USA
McDermott, Michael
[
4
]
Wartofsky, Leonard
论文数:
0
引用数:
0
h-index:
0
机构:
Georgetown Univ, Washington, DC 20057 USA
Univ Hlth Sci, Bethesda, MD USA
Georgetown Univ, Washington, DC 20057 USA
Wartofsky, Leonard
[
1
,
2
]
Emerson, Charles
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Massachusetts, Worcester, MA 01605 USA
Georgetown Univ, Washington, DC 20057 USA
Emerson, Charles
[
5
]
机构
:
[1]
Georgetown Univ, Washington, DC 20057 USA
[2]
Univ Hlth Sci, Bethesda, MD USA
[3]
Harvard Univ, Sch Med, Boston, MA USA
[4]
Univ Colorado, Denver, CO 80202 USA
[5]
Univ Massachusetts, Worcester, MA 01605 USA
来源
:
THYROID
|
2008年
/ 18卷
/ 05期
关键词
:
D O I
:
10.1089/thy.2008.0109
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:487 / 490
页数:4
相关论文
共 50 条
[31]
FDA revises drug labels to clarify information for health professionals
Wechsler, J
论文数:
0
引用数:
0
h-index:
0
Wechsler, J
FORMULARY,
2006,
41
(03)
: 162
-
163
[32]
FDA revises field inspections to reflect global market and quality initiatives
Wechsler, Jill
论文数:
0
引用数:
0
h-index:
0
Wechsler, Jill
Pharmaceutical Technology,
2015,
39
(05)
[33]
FDA Revises Field Inspections to Reflect Global Market and Quality Initiatives
Wechsler, Jill
论文数:
0
引用数:
0
h-index:
0
Wechsler, Jill
BIOPHARM INTERNATIONAL,
2015,
28
(05)
: 8
-
+
[34]
Requirements for FDA Approval
Basu, Sankar
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Device Evaluat, Rockville, MD 20850 USA
US FDA, Off Device Evaluat, Rockville, MD 20850 USA
Basu, Sankar
PROCEEDINGS OF LIGHT-ACTIVATED TISSUE REGENERATION AND THERAPY CONFERENCE,
2008,
12
: 269
-
269
[35]
CMS Revises Reporting Requirements for Physicians, Nonphysician Practitioners, and Suppliers
Turner, Susan A.
论文数:
0
引用数:
0
h-index:
0
Turner, Susan A.
GERIATRIC NURSING,
2009,
30
(02)
: 124
-
125
[36]
Factors That Influence FDA Decisions for Postmarketing Requirements and Commitments During Review of Oncology Products
Hyogo, Atsushi
论文数:
0
引用数:
0
h-index:
0
机构:
Kitasato Univ, Tokyo, Japan
Kitasato Univ, Tokyo, Japan
Hyogo, Atsushi
Kaneko, Masayuki
论文数:
0
引用数:
0
h-index:
0
机构:
Kitasato Univ, Tokyo, Japan
Kitasato Univ, Tokyo, Japan
Kaneko, Masayuki
Narukawa, Mamoru
论文数:
0
引用数:
0
h-index:
0
机构:
Kitasato Univ, Tokyo, Japan
Kitasato Univ, Tokyo, Japan
Narukawa, Mamoru
JOURNAL OF ONCOLOGY PRACTICE,
2018,
14
(01)
: 38
-
+
[37]
Japan's PMDA revises precautions for various products
Reactions Weekly,
2015,
1572
(1)
: 6
-
6
[38]
Lab accreditation council revises food chemistry program requirements
不详
论文数:
0
引用数:
0
h-index:
0
不详
QUALITY PROGRESS,
2000,
33
(01)
: 25
-
25
[39]
Adverse events with different levothyroxine products?
Reactions Weekly,
2021,
1858
(1)
: 2
-
2
[40]
Interaction between ritonavir products and levothyroxine
Reactions Weekly,
2018,
1725
(1)
: 2
-
2
←
1
2
3
4
5
→